Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting

A secondary analysis

Amy J. Masiongale, Barbara Jane Threatt Garvin, Marguerite Murphy, Vallire D. Hooper, Jan Odom-Forren, James I. Masiongale, Stephen Warwick Looney

Research output: Contribution to journalArticle

Abstract

Postoperative nausea and vomiting (PONV) continue to be among the most undesirable and distressing complications following general anesthesia, affecting 20% to 30% of all surgical patients and up to 70% of patients with multiple known risk factors. The purpose of this study was to reexamine the effectiveness of metoclopramide in the prevention of PONV when stratified by PONV risk scores. Secondary data from 2,116 adult ambulatory surgical patients were analyzed. Participants were, on average (SD), 49.7 (15.4) years of age, with a mean body mass index of 28.3 (6.9) kg/m2, and were primarily female (65%). Risk scores for PONV ranged from 0 to 4, with a mean of 2.6 (1.0). Metoclopramide, 10 mg intravenously (IV) alone; metoclopramide, 10 mg IV, combined with ondansetron, 4 mg IV; and metoclopramide, 10 mg IV, combined with dexamethasone, 8 mg IV, and ondansetron, 4 mg IV, had a beneficial effect for adult ambulatory surgical patients with PONV risk scores of 1 to 4. Although this cohort study had limitations, future studies should investigate metoclopramide based on risk score recommendations, and guidelines should be reevaluated.

Original languageEnglish (US)
Pages (from-to)213-219
Number of pages7
JournalAANA Journal
Volume86
Issue number3
StatePublished - Jun 1 2018

Fingerprint

Postoperative Nausea and Vomiting
Metoclopramide
Ondansetron
General Anesthesia
Dexamethasone
Body Mass Index
Cohort Studies
Guidelines

Keywords

  • Metoclopramide
  • Nausea and vomiting
  • Postoperative
  • Prophylaxis
  • Risk

ASJC Scopus subject areas

  • Medical–Surgical
  • Advanced and Specialized Nursing
  • Anesthesiology and Pain Medicine

Cite this

Masiongale, A. J., Garvin, B. J. T., Murphy, M., Hooper, V. D., Odom-Forren, J., Masiongale, J. I., & Looney, S. W. (2018). Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting: A secondary analysis. AANA Journal, 86(3), 213-219.

Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting : A secondary analysis. / Masiongale, Amy J.; Garvin, Barbara Jane Threatt; Murphy, Marguerite; Hooper, Vallire D.; Odom-Forren, Jan; Masiongale, James I.; Looney, Stephen Warwick.

In: AANA Journal, Vol. 86, No. 3, 01.06.2018, p. 213-219.

Research output: Contribution to journalArticle

Masiongale, AJ, Garvin, BJT, Murphy, M, Hooper, VD, Odom-Forren, J, Masiongale, JI & Looney, SW 2018, 'Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting: A secondary analysis', AANA Journal, vol. 86, no. 3, pp. 213-219.
Masiongale AJ, Garvin BJT, Murphy M, Hooper VD, Odom-Forren J, Masiongale JI et al. Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting: A secondary analysis. AANA Journal. 2018 Jun 1;86(3):213-219.
Masiongale, Amy J. ; Garvin, Barbara Jane Threatt ; Murphy, Marguerite ; Hooper, Vallire D. ; Odom-Forren, Jan ; Masiongale, James I. ; Looney, Stephen Warwick. / Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting : A secondary analysis. In: AANA Journal. 2018 ; Vol. 86, No. 3. pp. 213-219.
@article{518cbf201a774a50b1c482f2da4cbab8,
title = "Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting: A secondary analysis",
abstract = "Postoperative nausea and vomiting (PONV) continue to be among the most undesirable and distressing complications following general anesthesia, affecting 20{\%} to 30{\%} of all surgical patients and up to 70{\%} of patients with multiple known risk factors. The purpose of this study was to reexamine the effectiveness of metoclopramide in the prevention of PONV when stratified by PONV risk scores. Secondary data from 2,116 adult ambulatory surgical patients were analyzed. Participants were, on average (SD), 49.7 (15.4) years of age, with a mean body mass index of 28.3 (6.9) kg/m2, and were primarily female (65{\%}). Risk scores for PONV ranged from 0 to 4, with a mean of 2.6 (1.0). Metoclopramide, 10 mg intravenously (IV) alone; metoclopramide, 10 mg IV, combined with ondansetron, 4 mg IV; and metoclopramide, 10 mg IV, combined with dexamethasone, 8 mg IV, and ondansetron, 4 mg IV, had a beneficial effect for adult ambulatory surgical patients with PONV risk scores of 1 to 4. Although this cohort study had limitations, future studies should investigate metoclopramide based on risk score recommendations, and guidelines should be reevaluated.",
keywords = "Metoclopramide, Nausea and vomiting, Postoperative, Prophylaxis, Risk",
author = "Masiongale, {Amy J.} and Garvin, {Barbara Jane Threatt} and Marguerite Murphy and Hooper, {Vallire D.} and Jan Odom-Forren and Masiongale, {James I.} and Looney, {Stephen Warwick}",
year = "2018",
month = "6",
day = "1",
language = "English (US)",
volume = "86",
pages = "213--219",
journal = "AANA Journal",
issn = "0094-6354",
publisher = "AANA Publishing Inc.",
number = "3",

}

TY - JOUR

T1 - Reexamining metoclopramide's role in the prevention of postoperative nausea and vomiting

T2 - A secondary analysis

AU - Masiongale, Amy J.

AU - Garvin, Barbara Jane Threatt

AU - Murphy, Marguerite

AU - Hooper, Vallire D.

AU - Odom-Forren, Jan

AU - Masiongale, James I.

AU - Looney, Stephen Warwick

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Postoperative nausea and vomiting (PONV) continue to be among the most undesirable and distressing complications following general anesthesia, affecting 20% to 30% of all surgical patients and up to 70% of patients with multiple known risk factors. The purpose of this study was to reexamine the effectiveness of metoclopramide in the prevention of PONV when stratified by PONV risk scores. Secondary data from 2,116 adult ambulatory surgical patients were analyzed. Participants were, on average (SD), 49.7 (15.4) years of age, with a mean body mass index of 28.3 (6.9) kg/m2, and were primarily female (65%). Risk scores for PONV ranged from 0 to 4, with a mean of 2.6 (1.0). Metoclopramide, 10 mg intravenously (IV) alone; metoclopramide, 10 mg IV, combined with ondansetron, 4 mg IV; and metoclopramide, 10 mg IV, combined with dexamethasone, 8 mg IV, and ondansetron, 4 mg IV, had a beneficial effect for adult ambulatory surgical patients with PONV risk scores of 1 to 4. Although this cohort study had limitations, future studies should investigate metoclopramide based on risk score recommendations, and guidelines should be reevaluated.

AB - Postoperative nausea and vomiting (PONV) continue to be among the most undesirable and distressing complications following general anesthesia, affecting 20% to 30% of all surgical patients and up to 70% of patients with multiple known risk factors. The purpose of this study was to reexamine the effectiveness of metoclopramide in the prevention of PONV when stratified by PONV risk scores. Secondary data from 2,116 adult ambulatory surgical patients were analyzed. Participants were, on average (SD), 49.7 (15.4) years of age, with a mean body mass index of 28.3 (6.9) kg/m2, and were primarily female (65%). Risk scores for PONV ranged from 0 to 4, with a mean of 2.6 (1.0). Metoclopramide, 10 mg intravenously (IV) alone; metoclopramide, 10 mg IV, combined with ondansetron, 4 mg IV; and metoclopramide, 10 mg IV, combined with dexamethasone, 8 mg IV, and ondansetron, 4 mg IV, had a beneficial effect for adult ambulatory surgical patients with PONV risk scores of 1 to 4. Although this cohort study had limitations, future studies should investigate metoclopramide based on risk score recommendations, and guidelines should be reevaluated.

KW - Metoclopramide

KW - Nausea and vomiting

KW - Postoperative

KW - Prophylaxis

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=85052612191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052612191&partnerID=8YFLogxK

M3 - Article

VL - 86

SP - 213

EP - 219

JO - AANA Journal

JF - AANA Journal

SN - 0094-6354

IS - 3

ER -